Arzeda logo — The Protein Design Company (TM) - new proteins and biochemis...

Arzeda

The Protein Design Company (TM) - new proteins and biochemistry for the production of valuable sustainable molecules

Founded 2009 United States Seattle, United States 78 employees Unknown Total: $118.00M AI, Biotechnology +1

General Information

Company Name Arzeda
Founded Year 2009
Location United States Seattle, United States
Founders / Decision Makers
Team member
Employees 78
Industries AI, Biotechnology, Manufacturing
Funding Stage Unknown
Social

Get notified when Arzeda moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

AI Insight

Bounce Watch AI
2 months ago

Arzeda's extensive website update in June 2026, marked by a 71.74% change, indicates a proactive strategic communications shift. This significant digital refresh, following recent Late VC and grant funding, likely points towards upcoming product advancements, new commercial partnerships, or a refined market strategy. It suggests the company is preparing to showcase substantial progress in its protein design and sustainable biomanufacturing initiatives.

Signal Types
Strategic Update Marketing
Strategic Labels
Strategic Communication Market Repositioning Growth Readiness
Next Move: Announcement
·
Impact: 7/10
·
Ideal For: Growth Equity — Synthetic Biology & Sustainable Biomanufacturing

About Arzeda

Arzeda, founded in 2009, is a pioneering company in the fields of AI, Biotechnology, and Manufacturing. It focuses on developing innovative proteins and enzymes that aim to revolutionize the production of sustainable molecules. As The Protein Design Company™, Arzeda aligns its offerings with performance, cost-effectiveness, and sustainability.

The company has strategically partnered with Fortune 500 companies to expand its influence and utility across industries such as polymers, pharmaceuticals, and industrial chemicals. Through these collaborations, Arzeda has curated an extensive portfolio of specialty chemical products for advanced applications.

Headquartered in the United States, Arzeda recently secured a $7.80M grant from the National Science Foundation on September 1, 2025, emphasizing its credibility and growth potential within synthetic biology. These developments position Arzeda as a compelling opportunity for investors interested in leveraging cutting-edge biotechnological solutions for sustainable production.

Taxonomy: Protein Design, Synthetic Biology, Enzyme Development, Specialty Chemicals, Biocatalysis, Sustainable Molecules, AI Algorithms, Physics-based Protein Design, Industrial Chemicals, Polymers, Pharmaceutical Applications, Bio-based Chemicals, Fortune 500 Partnerships, Intelligent Protein Design, Advanced Applications

Services & Products

AI-driven protein design
BioSolution creation
Product manufacturing and scaling
Collaborative development with industry leaders

Target Customers

Food and Nutrition companies Home and Personal Care brands Advanced Material industries Pharmaceutical organizations Global consumer brands

Funding Rounds & Investors (14)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1
Investor
01 Sep 2025
Late Vc •••••• 7
Investor Investor Investor Investor Investor
•••• ••••
01 Sep 2024
Late Vc •••••• - 01 Nov 2023
Series B •••••• 8
Investor Investor Investor Investor Investor Investor Investor
•••• ••••
01 Mar 2022
Series B •••••• 2
Investor
•••• ••••
01 Nov 2020

View All 14 Funding Rounds

Arzeda Alternatives & Competitors

View All Alternatives
Arzeda vs

The Power of Chemistry

9 employees
Industrial, Manufacturing
Arzeda vs

Engineering a Sustainable Future

Seed
6 employees
Biotechnology, Clean Energy
Arzeda vs

Innovative solutions and specialty chemicals driving industrial and commercial excellence.

Life Sciences, Manufacturing

FAQ About Arzeda

The Protein Design Company (TM) - new proteins and biochemistry for the production of valuable sustainable molecules
Arzeda was founded in 2009.
Arzeda is headquartered in Seattle, United States.
Arzeda operates in the following industries: AI, Biotechnology, Manufacturing.
Arzeda has approximately 78 employees.
Arzeda has completed 14 funding rounds, raising a total of $118.00M. The latest funding stage is Unknown.
Arzeda offers: AI-driven protein design, BioSolution creation, Product manufacturing and scaling, Collaborative development with industry leaders.
Top alternatives and competitors to Arzeda include Catalyst Drilling Fluids, SYNOVANCE, Rockwood Holdings, Eagle-Chemicals Group, Saltigo. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Arzeda and Catalyst Drilling Fluids are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Arzeda and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy